Across TCGA pan-cancer cohorts, C8G Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated C8G data layer compared with 28 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher C8G Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C8G expression acts as an unfavorable survival marker.
COAD and PRAD are the cancer types where C8G Mutation most reproducibly stratifies survival.